In the present study, EEAR was demonstrated to reduce the expression of inflammatory factors in the lungs of rats with ALI in both in vivo and ex vivo experiments via inhibition of the TLR4/NF-κB signaling pathway, thereby alleviating the inflammatory response to ALI. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.